Paper · 41535945
Ferroptosis and metastasis: molecular checkpoints, microenvironmental dynamics, and therapeutic opportunities.
Guo F and 9 others. Mol Cancer, 2026. Cited by 12 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Ferroptosis and metastasis: molecular checkpoints, microenvironmental dynamics, and therapeutic opportunities. Papers, record 41535945. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41535945
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ferroptosis and metastasis: molecular checkpoints, microenvironmental dynamics, and therapeutic opportunities.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferroptosis | Major topic |
| Tumor Microenvironment | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Animals | |
| Neoplasm Metastasis | |
| Iron | |
| Lipid Peroxidation | |
| Metabolic Reprogramming |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References193
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39,812,999 | Elucidating stearoyl metabolism and NCOA4-mediated ferroptosis in gastric cancer liver metastasis through multi-omics single-cell integrative mendelian analysis: advancing personalized immunotherapy strategies. | Discov Oncol | 2025 | https://conductscience.org/library/papers/39812999 | PubMed |
| 2 | 24,604,199 | Crystal structures of nucleotide-free and glutathione-bound mitochondrial ABC transporter Atm1. | Science | 2014 | https://conductscience.org/library/papers/24604199 | PubMed |
| 3 | 37,215,985 | Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37215985 | PubMed |
| 4 | 30,467,171 | ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. | Science | 2018 | https://conductscience.org/library/papers/30467171 | PubMed |
| 5 | 32,165,281 | Lipid peroxidation and ferroptosis: The role of GSH and GPx4. | Free Radic Biol Med | 2020 | https://conductscience.org/library/papers/32165281 | PubMed |
| 6 | 36,788,538 | Hepatocyte SGK1 activated by hepatic ischemia-reperfusion promotes the recurrence of liver metastasis via IL-6/STAT3. | J Transl Med | 2023 | https://conductscience.org/library/papers/36788538 | PubMed |
| 7 | 29,883,798 | Crystal structure and functional characterization of selenocysteine-containing glutathione peroxidase 4 suggests an alternative mechanism of peroxide reduction. | Biochim Biophys Acta Mol Cell Biol Lipids | 2018 | https://conductscience.org/library/papers/29883798 | PubMed |
| 8 | 30,202,049 | BAP1 links metabolic regulation of ferroptosis to tumour suppression. | Nat Cell Biol | 2018 | https://conductscience.org/library/papers/30202049 | PubMed |
| 9 | 37,138,326 | Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis. | J Hematol Oncol | 2023 | https://conductscience.org/library/papers/37138326 | PubMed |
| 10 | 33,689,883 | KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma. | Biochem Biophys Res Commun | 2021 | https://conductscience.org/library/papers/33689883 | PubMed |
1 to 10 of 193
See all 193 referencesCited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,871,413 | Molecular and microenvironmental networks driving tumor dormancy: pathological mechanisms and emerging clinical strategies. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42871413 | PubMed |
| 42,842,069 | Ferroptosis and tumor microenvironment: orchestrating therapy resistance, immune evasion, and metastatic events. | Med Oncol | 2026 | https://conductscience.org/library/papers/42842069 | PubMed |
| 42,830,873 | Liver Metastases from Colorectal Cancer: From Pathogenesis to Current Treatment. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42830873 | PubMed |
| 42,794,496 | The Emerging Role of Ferroptosis in Pediatric Cancer Biology and Therapy. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794496 | PubMed |
| 42,469,227 | A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42469227 | PubMed |
| 42,415,857 | Oxidative stress and antioxidants in breast cancer: a double-edged sword. | Front Oncol | 2026 | https://conductscience.org/library/papers/42415857 | PubMed |
| 42,319,595 | From Ferroptotic Stress to Stemness: TNT-Mediated EMT Plasticity in Cancer Progression. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/42319595 | PubMed |
| 42,310,170 | Zinc supplementation ameliorates colitis in mice by sensitizing pathogenic CD4+ T cells to ferroptosis. | Clin Exp Med | 2026 | https://conductscience.org/library/papers/42310170 | PubMed |
| 42,253,950 | From gut-reproductive microbiota to ferroptosis: a comprehensive insight into the molecular-pathogenicity of endometriosis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42253950 | PubMed |
| 42,157,790 | The Crosstalk Between Epithelial-Mesenchymal Transition and Anoikis Resistance: A New Perspective of Traditional Chinese Medicine to Prevent Tumor Metastasis. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42157790 | PubMed |
1 to 10 of 14
See all 14 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41535945
GET https://conductscience.org/api/papers/v1/41535945/references?page=2